Reduced‐intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first‐donor origin
Authors:
Open Access
- 25 February 2003
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 72 (3) , 220-222
Abstract
A male patient had a relapse of myelodysplastic syndrome (MDS) 2 years after BMT from a female matched unrelated donor. Conventional cytogenetics, FISH, and short‐tandem repeat chimerism analysis proved a relapse of donor origin. He underwent reduced‐intensity BMT after a conditioning with fludarabine and busulfan, since he had impaired renal, liver, and pulmonary functions. Chimerism analysis on day 28 after the second BMT showed mixed chimerism of the first and the second donors, which later turned to full second‐donor chimerism on day 60. He developed grade II acute GVHD of the skin and cytomegalovirus reactivation, but both were improved with methylprednisolone and ganciclovir, respectively. He remains in complete remission 6 months after the second BMT. Reduced‐intensity second BMT from an alternative donor appeared to be a tolerable treatment option for donor‐derived leukemia/MDS after the first conventional transplantation. Am. J. Hematol. 72:220–222, 2003.Keywords
This publication has 16 references indexed in Scilit:
- Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantationBone Marrow Transplantation, 2002
- Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemiaBone Marrow Transplantation, 2002
- Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemiaBone Marrow Transplantation, 2002
- Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulinBone Marrow Transplantation, 2002
- Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluationTransplantation, 2002
- Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaBone Marrow Transplantation, 2001
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomesBlood, 2001
- Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in JapanBone Marrow Transplantation, 2001
- Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detectionBone Marrow Transplantation, 1999
- The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantationLeukemia Research, 1982